CT
BSX icon

Clearstead Trust’s Boston Scientific BSX Stock Holding History

Clearstead Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$982 Sell
23
-957
-98% -$52K ﹤0.01% 937
2026
Q1 		$61.5K Sell
980
-1,741
-64% -$139K 0.01% 293
2025
Q4 		$259K Sell
2,721
-998
-27% -$97.8K 0.04% 164
2025
Q3 		$363K Sell
3,719
-232
-6% -$24K 0.06% 131
2025
Q2 		$424K Buy
3,951
+51
+1% +$5.16K 0.08% 119
2025
Q1 		$393K Hold
3,900
– – 0.09% 105
2024
Q4 		$348K Buy
+3,900
New +$343K 0.08% 116

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Clearstead Trust's BSX Position: Q2 2026 in Review

Clearstead Trust reduced its Boston Scientific (BSX) stake by 98% in Q2 2026, selling an estimated $52K and leaving 23 shares worth $982. The position accounts for ﹤0.01% of the portfolio, ranked #937.

Clearstead Trust first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $424K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Clearstead Trust held 23 shares of Boston Scientific worth $982 as of Q2 2026.
  • Clearstead Trust sold 957 Boston Scientific shares in Q2 2026, an estimated $52K.
  • Boston Scientific made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #937 holding.
  • Clearstead Trust first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Clearstead Trust's Boston Scientific position peaked at $424K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.